Form D · Other
Dolores Labs, Inc.
San Francisco, CA · CIK 0001477518
Offering snapshot reported Mar 17, 2010 · SEC filing
- Reported sold
- $5.08M Offering amount: $5.08M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 8, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2010 | Initial | $5,080,471 | No comparison | 16 | SEC filing |
| Nov 24, 2009 | Initial | $1,149,998 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-136402
5,080,471.20 total offering amount and total amount sold.
Source: Form D, filed Mar 17, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lukas Biewald | Director, Executive |
| James Cham | Director |
| Ajay Chopra | Director |
| Travis Kalanick | Director |
| Gary Kremen | Director |
| Chris Van Pelt | Director, Executive |
| Chris Van Pelt | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
455 Valencia Street
San Francisco, CA, 94103
San Francisco, CA, 94103